Filter
43
Filtered Results: 43
Text search:
fluvoxamine
Featured
Recommendations
4
New Publications
4
Language
Document type
No document type
28
Guidelines
11
Manuals
3
Studies & Reports
1
Countries / Regions
Ethiopia
3
Latin America and the Carribbean
2
South Africa
2
Singapore
1
Global
1
Authors & Publishers
Publication Years
Category
Countries
8
Clinical Guidelines
1
Key Resources
1
Toolboxes
Mental Health
29
COVID-19
7
Pharmacy
4
Conflict
1
AMR
1
Fourth Edition
Le trouble anxiété de séparation (TAS) représente environ la moitié de l’ensemble des troubles anxieux
(Cartwright-Harton et al, 2006). La plupart des troubles anxieux pédiatriques
présentent les mêmes critères diagnostics que chez l’adulte à l’exception du TAS,
actuellement class...
An Evidence-Based Treatment Guide for Clinicians
Introduction
Chapter A.7
This guide was developed by AACAP to give reliable information about medication
used to treat bipolar disorder in children and adolescents to parents whose children
have been diagnosed with the illness.
Anxiety disorders
Chapter F.3
Troubles de l'humeur
Chapitre E.1
Edition en français
Traduction : Marie Boussaud, Julie Brunelle Sous la direction de : David Cohen Avec le soutien de la SFPEADA
The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalised anxiety and sleep disorders; obsessive-compulsive disorders and panic attacks; and alcohol and opioid dependence
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
Psychiatry and Pediatrics
Chapter I.4
Ongoing Living Update of COVID-19 Therapeutic Options: Summary of Evidence, Rapid Review 22 February 2022
recommended
This document includes the results of a rapid systematic review of current available literature. The information included in this review reflects the evidence as of the date posted in the document. In recognition of the fact that there are numerous ongoing clinical studies, PAHO will periodically up...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information...
How to recognise Post-Traumatic Stress Disorder | The nature and cause of Post-Traumatic Stress Disorder | Treatment and referral | Sources of further information | Compiled by the Scientific & Advisory Board Members of the South African Depression & Anxiety Group, and reviewed by the MRC Research U...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
Suchtmedizinische Reihe
Band 5
Accessed: 14.03.2019
Trastornos del ánimo
Capítulo E.1
Traducción de la versión inglesa del 2015
